Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1990-8-14
pubmed:abstractText
The remission rates achieved with the combination of vincristine and etoposide are comparable with other frequently employed therapeutic regimens (ACO/EPICO, cisplatin/etoposide). The combination of etoposide with vincristine represents an alternative, in particular with respect to a merely palliative approach to treatment.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0934-8387
pubmed:author
pubmed:issnType
Print
pubmed:volume
44 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
582-3
pubmed:dateRevised
2009-4-7
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
[Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
pubmed:affiliation
Zentralkrankenhaus Gauting/München.
pubmed:publicationType
Journal Article, English Abstract